Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alcohol Use in Patients with Chronic Liver Disease
Daniel Fuster, Jeffrey H. Samet
New England Journal of Medicine (2018) Vol. 379, Iss. 13, pp. 1251-1261
Closed Access | Times Cited: 181

Showing 1-25 of 181 citing articles:

Necroptosis in the Pathophysiology of Disease
Mitri K. Khoury, Kartik Gupta, Sarah Franco, et al.
American Journal Of Pathology (2019) Vol. 190, Iss. 2, pp. 272-285
Open Access | Times Cited: 243
Fibrosis and alcohol-related liver disease
Carolin Lackner, Dina Tiniakos
Journal of Hepatology (2019) Vol. 70, Iss. 2, pp. 294-304
Open Access | Times Cited: 231
Impact of Alcohol Use Disorder Treatment on Clinical Outcomes Among Patients With Cirrhosis
Shari S. Rogal, Ada O. Youk, Hongwei Zhang, et al.
Hepatology (2019) Vol. 71, Iss. 6, pp. 2080-2092
Open Access | Times Cited: 157
Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial
Mads Israelsen, Bjørn Stæhr Madsen, Nikolaj Torp, et al.
˜The œLancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 6, pp. 523-532
Open Access | Times Cited: 42
Longer time spent at home during COVID-19 pandemic is associated with binge drinking among US adults
Sitara M. Weerakoon, Katelyn K. Jetelina, Gregory Knell
The American Journal of Drug and Alcohol Abuse (2020) Vol. 47, Iss. 1, pp. 98-106
Closed Access | Times Cited: 104
MAFLD: Renovation of clinical practice and disease awareness of fatty liver
Takumi Kawaguchi, Tsubasa Tsutsumi, Dan Nakano, et al.
Hepatology Research (2021) Vol. 52, Iss. 5, pp. 422-432
Closed Access | Times Cited: 89
Microbial metabolites in non-alcoholic fatty liver disease
Da Zhou, Jian‐Gao Fan
World Journal of Gastroenterology (2019) Vol. 25, Iss. 17, pp. 2019-2028
Open Access | Times Cited: 78
MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
Takumi Kawaguchi, Tsubasa Tsutsumi, Dan Nakano, et al.
Clinical and Molecular Hepatology (2021) Vol. 28, Iss. 2, pp. 150-163
Open Access | Times Cited: 76
Trends in the disease burden of HBV and HCV infection in China from 1990-2019
Tingting Yue, Quanquan Zhang, Ting Cai, et al.
International Journal of Infectious Diseases (2022) Vol. 122, pp. 476-485
Open Access | Times Cited: 61
NAFLD, MAFLD, and beyond: one or several acronyms for better comprehension and patient care
Piero Portincasa
Internal and Emergency Medicine (2023) Vol. 18, Iss. 4, pp. 993-1006
Open Access | Times Cited: 25
Programmed cell death in hepatic fibrosis: current and perspectives
Ju-Lu Lu, Chuan-Xin Yu, Li-Jun Song
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 24
Alcohol-associated liver disease—Global epidemiology
Fredrik Åberg, Z. Gordon Jiang, Helena Cortez‐Pinto, et al.
Hepatology (2024) Vol. 80, Iss. 6, pp. 1307-1322
Closed Access | Times Cited: 13
Metabolic dysfunction-associated steatotic liver disease: Evolution of the final terminology
Piero Portincasa, György Baffy
European Journal of Internal Medicine (2024) Vol. 124, pp. 35-39
Open Access | Times Cited: 10
Alcohol-associated liver cancer
Yaojie Fu, Luca Maccioni, Xin Wei Wang, et al.
Hepatology (2024) Vol. 80, Iss. 6, pp. 1462-1479
Closed Access | Times Cited: 9
Programmed cell death in alcohol-associated liver disease
Tatsunori Miyata, Laura E. Nagy
Clinical and Molecular Hepatology (2020) Vol. 26, Iss. 4, pp. 618-625
Open Access | Times Cited: 66
Alcoholic fatty liver disease inhibited the co-expression of Fmo5 and PPARα to activate the NF-κB signaling pathway, thereby reducing liver injury via inducing gut microbiota disturbance
Lingjian Kong, Jing Chen, Xiaoli Ji, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 47
SIRT2-mediated deacetylation and deubiquitination of C/EBPβ prevents ethanol-induced liver injury
Yingting Zhang, Xi‐Dai Long, Xin Ruan, et al.
Cell Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 41
Alcohol-associated liver disease: Epidemiology and management
Helena Hernández-Évole, Natalia Jiménez, Elisa Pose, et al.
Annals of Hepatology (2023) Vol. 29, Iss. 1, pp. 101162-101162
Open Access | Times Cited: 21
Alleviation of Alcoholic Fatty Liver by Dendrobium officinale Flower Extracts due to Regulation of Gut Microbiota and Short-Chain Fatty Acids in Mice Exposed to Chronic Alcohol
Jingchi Zhang, Jiakun Fan, Hui Luo, et al.
Foods (2023) Vol. 12, Iss. 7, pp. 1428-1428
Open Access | Times Cited: 16
Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action
Lamia Haque, Paola Zuluaga, Roberto Muga, et al.
Addiction Science & Clinical Practice (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 5
Targeting liver aldehyde dehydrogenase-2 prevents heavy but not moderate alcohol drinking
Adrien Guillot, Tianyi Ren, Tony Jourdan, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 51, pp. 25974-25981
Open Access | Times Cited: 53
Protective effects of polysaccharides on hepatic injury: A review
Ye Yuan, Lihe Che, Chong Qi, et al.
International Journal of Biological Macromolecules (2019) Vol. 141, pp. 822-830
Closed Access | Times Cited: 50
Oxidative Stress—A Key Player in the Course of Alcohol-Related Liver Disease
Agata Michalak, Tomasz Lach, Halina Cichoż‐Lach
Journal of Clinical Medicine (2021) Vol. 10, Iss. 14, pp. 3011-3011
Open Access | Times Cited: 39
Alcohol Use Disorder and Alcohol-Associated Liver Disease
Resham­ Ramkissoon
Alcohol research (2022) Vol. 42, Iss. 1
Open Access | Times Cited: 27
RAGE promotes dysregulation of iron and lipid metabolism in alcoholic liver disease
Yunjia Li, Mengchen Qin, Weichao Zhong, et al.
Redox Biology (2022) Vol. 59, pp. 102559-102559
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top